Meloxicam sodium salt hydrate

• 产品号: M3935
• CAS号: 71125-39-8(anhydrous)
• 分子式: C14H14N3NaO5S2
• 分子量: 391.39783

产品别名

• 标题: Meloxicam sodium salt hydrate
• IUPAC标准名: sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-1,1-dioxo-2H-1λ^6,2-benzothiazin-4-olate hydrate
• IUPAC传统名: sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-1,1-dioxo-1λ^6,2-benzothiazin-4-olate hydrate
• 别名: Mobec sodium salt hydrate; Metacam sodium salt hydrate; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide sodium hydrate; UH-AC 62XX sodium salt hydrate

产品登记号

• CAS号: 71125-39-8(anhydrous)
• MDL号: MFCD11046047
• PubChem SID: 24278802

产品性质

• 外观: yellow
• 溶解度: DMSO: soluble
• 溶解度: H2O: soluble
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• RID/ADR: UN 2811 6.1/PG 3
• 危险公开号: 22-36/37/38
• 安全公开号: 26
• 联合国危险货物等级: 6.1
• 联合国危险货物编号: 2811
• 联合国危险货物包装类别(PG): 3
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Meloxicam, a member of the oxicam family, is a non-steroidal anti-inflammatory drug (NSAID) that shows 300-fold selectivity for cyclooxygenase-2 (COX-2) vs cyclooxygenase-1 (COX-1). Meloxicam has been shown to abolish thymulin-induced increases of cytokines and NGF in the liver of rats. Meloxicam also suppresses tumor growth and may be capable of antagonizing cachexia in vitro.